Sabra Health Care REIT reported third quarter 2026 total revenues of $249.6 million, up from $190.0 million a year earlier, and net income of $0.11 per diluted share, compared with $0.09. Normalized FFO was $0.39 per diluted share, up from $0.36, and the company updated 2026 normalized FFO guidance to $1.540 to $1.550 per share, which its CEO said was increased at the midpoint.
Total revenues were $249.6 million for the quarter, versus $190.0 million in the third quarter of 2025.
Normalized FFO was $0.39 per diluted share, versus $0.36; normalized AFFO was $0.41, versus $0.38.
Full-year 2026 guidance: net income $0.265 to $0.275 per share and normalized FFO $1.540 to $1.550 per share.
Sabra was awarded an additional $425 million of investments and declared a quarterly dividend of $0.30 per share, payable November 30, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Sabra Health Care REIT's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$356.88M
+25.4%
$0.64
+18.5%
43.6%
FY2024
$284.58M
+20.5%
$0.54
+800.0%
44.5%
FY2023
$236.15M
+26.5%
$0.06
—
5.8%
FY2022
$186.67M
+20.0%
$-0.34
—
-41.6%
FY2021
$155.51M
-0.3%
$-0.52
-177.6%
-72.8%
Frequently asked questions
When is Sabra Health Care REIT's next earnings date?
Sabra Health Care REIT has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Sabra Health Care REIT earn last quarter?
For the quarter ended Sep 2026, Sabra Health Care REIT reported diluted EPS of $0.11 (+22.2% year over year) on revenue of $143.16M (+55.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.